ABSTRACT
Disorders of consciousness (DoC) are states of impaired arousal or awareness. Deep brain stimulation (DBS) is a potential treatment, but outcomes vary, possibly due to differences in patient characteristics, electrode placement, or stimulation of specific brain networks. We studied 40 patients with DoC who underwent DBS targeting the thalamic centromedian-parafascicular complex. Better-preserved gray matter, especially in the striatum, correlated with consciousness improvement.
Stimulation was most effective when electric fields extended into parafascicular and subparafascicular nuclei—ventral to the centromedian nucleus, near the midbrain— and when it engaged projection pathways of the ascending arousal network, including the hypothalamus, brainstem, and frontal lobe. Moreover, effective DBS sites were connected to networks similar to those underlying impaired consciousness due to generalized absence seizures and acquired lesions. These findings support the therapeutic potential of DBS for DoC, emphasizing the importance of precise targeting and revealing a broader link between effective DoC treatment and mechanisms underlying other conscciousness-impairing conditions.
Competing Interest Statement
AELW, MR, HF, FLWVJS, JT, SBS, JL, MMJC, KB, MUF, RJ, JEI, PWC, DF, ADB, BLE, and DC have no competing interests to report. MDF has intellectual property on the use of brain connectivity imaging to analyze lesions and guide brain stimulation, has consulted for Magnus Medical, Soterix, Abbott, Boston Scientific, and Tal Medical, and has received research funding from Neuronetics. AH reports lecture fees for Boston Scientific and is a consultant for Neuromodulation and Abbott. JDR has received past consulting payments from Medtronic, Corlieve, ClearPoint, Medtronic, and NeuroPace, and currently consults for Turing Medical.
Funding Statement
AELW was supported by funding from the King Trust Postdoctoral Research Fellowship Program (Bank of America Private Bank, Trustee), the Program for Interdisciplinary Neuroscience at Mass General Brigham, and the LGS Foundation. MR and DC were supported by the Croatian Science Foundation (CSF-IP-2020-02-4308). FLWVJS was supported by the National Institutes of Health (R01NS127892). JEI was supported by the National Institutes of Health (1RF1MH123195, 1R01AG070988, 1UM1MH130981, and 1RF1AG080371). DF was supported by the American Academy of Neurology Clinical Research Training Scholarship, the Neurocritical Care Society Research Training Fellowship, and the University of Pennsylvania Center for Clinical Epidemiology and Biostatistics Research Program Award. MDF was supported by grants from the National Institutes of Health (R01MH113929, R21MH126271, R21NS123813, R01NS127892, R01MH130666, UM1NS132358), the Kaye Family Research Endowment, the Ellison / Baszucki Family Foundation, the Manley Family, and the May family. BLE was supported by the National Institutes of Health (R01NS138257, DP2HD101400), Chen Institute MGH Research Scholar Award, and the Massachusetts Institute of Technology/Mass General Hospital Brain Arousal State Control Innovation Center (BASCIC) project. AH was supported by the National Institutes of Health (R01MH130666, 1R01NS127892-01, 2R01 MH113929 and UM1NS132358) and the New Venture Fund (FFOR Seed Grant). JDR was supported by the National Institutes of Health (UH3NS109557A1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This was a retrospective analysis of a previous clinical study of patients with disorders of consciousness who underwent deep brain stimulation at Dubrava University Hospital in Zagreb Croatia. The clinical study received approval from the institutional review board of Dubrava University Hospital and the School of Medicine at the University of Zagreb in Croatia. Informed consent was obtained from patients' families or caregivers. Approval for retrospective data analysis performed in the current study was received from the Mass General Brigham institutional review board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos